Annual CFO
-$7.33 M
-$1.13 M-18.13%
October 1, 2024
Summary
- As of February 8, 2025, ANIX annual cash flow from operations is -$7.33 million, with the most recent change of -$1.13 million (-18.13%) on October 1, 2024.
- During the last 3 years, ANIX annual CFO has fallen by -$2.40 million (-48.54%).
- ANIX annual CFO is now -637.99% below its all-time high of $1.36 million, reached on October 31, 2015.
Performance
ANIX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$927.00 K
+$1.72 M+64.93%
October 1, 2024
Summary
- As of February 8, 2025, ANIX quarterly cash flow from operations is -$927.00 thousand, with the most recent change of +$1.72 million (+64.93%) on October 1, 2024.
- Over the past year, ANIX quarterly CFO has increased by +$1.04 million (+52.92%).
- ANIX quarterly CFO is now -119.92% below its all-time high of $4.65 million, reached on January 31, 2015.
Performance
ANIX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$7.33 M
+$1.04 M+12.44%
October 1, 2024
Summary
- As of February 8, 2025, ANIX TTM cash flow from operations is -$7.33 million, with the most recent change of +$1.04 million (+12.44%) on October 1, 2024.
- Over the past year, ANIX TTM CFO has dropped by -$1.13 million (-18.13%).
- ANIX TTM CFO is now -312.86% below its all-time high of $3.45 million, reached on January 31, 2015.
Performance
ANIX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ANIX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -18.1% | +52.9% | -18.1% |
| 3 y3 years | -48.5% | +35.9% | -25.8% |
| 5 y5 years | -54.7% | +35.9% | -25.8% |
ANIX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -48.5% | at low | -14.9% | +64.9% | -47.7% | +12.4% |
| 5 y | 5-year | -54.7% | at low | -14.9% | +64.9% | -48.5% | +12.4% |
| alltime | all time | -638.0% | +28.1% | -119.9% | +66.9% | -312.9% | +28.1% |
Anixa Biosciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2024 | -$7.33 M(+18.1%) | -$927.00 K(-64.9%) | -$7.33 M(-12.4%) |
| Jul 2024 | - | -$2.64 M(+81.5%) | -$8.38 M(+16.7%) |
| Apr 2024 | - | -$1.46 M(-36.9%) | -$7.18 M(+9.9%) |
| Jan 2024 | - | -$2.31 M(+17.3%) | -$6.53 M(+5.2%) |
| Oct 2023 | -$6.21 M(-4.4%) | -$1.97 M(+36.3%) | -$6.21 M(+6.4%) |
| Jul 2023 | - | -$1.45 M(+79.1%) | -$5.83 M(+0.8%) |
| Apr 2023 | - | -$807.00 K(-59.4%) | -$5.78 M(-20.6%) |
| Jan 2023 | - | -$1.99 M(+24.8%) | -$7.28 M(+12.2%) |
| Oct 2022 | -$6.49 M(+31.5%) | -$1.59 M(+14.1%) | -$6.49 M(+9.2%) |
| Jul 2022 | - | -$1.40 M(-39.5%) | -$5.94 M(-1.4%) |
| Apr 2022 | - | -$2.31 M(+92.6%) | -$6.03 M(+21.4%) |
| Jan 2022 | - | -$1.20 M(+14.5%) | -$4.96 M(+0.5%) |
| Oct 2021 | -$4.94 M(-20.0%) | -$1.04 M(-29.4%) | -$4.94 M(-7.0%) |
| Jul 2021 | - | -$1.48 M(+19.2%) | -$5.31 M(+3.7%) |
| Apr 2021 | - | -$1.24 M(+6.2%) | -$5.12 M(-5.8%) |
| Jan 2021 | - | -$1.17 M(-17.3%) | -$5.43 M(-12.1%) |
| Oct 2020 | -$6.18 M(+30.3%) | -$1.41 M(+9.5%) | -$6.18 M(+1.3%) |
| Jul 2020 | - | -$1.29 M(-17.0%) | -$6.10 M(+11.9%) |
| Apr 2020 | - | -$1.56 M(-18.7%) | -$5.45 M(+2.3%) |
| Jan 2020 | - | -$1.91 M(+43.2%) | -$5.33 M(+12.3%) |
| Oct 2019 | -$4.74 M(+11.0%) | -$1.34 M(+108.9%) | -$4.74 M(+7.1%) |
| Jul 2019 | - | -$640.10 K(-55.4%) | -$4.43 M(-10.7%) |
| Apr 2019 | - | -$1.43 M(+7.9%) | -$4.96 M(+16.2%) |
| Jan 2019 | - | -$1.33 M(+30.2%) | -$4.26 M(-0.2%) |
| Oct 2018 | -$4.27 M(+12.6%) | -$1.02 M(-12.7%) | -$4.27 M(+7.1%) |
| Jul 2018 | - | -$1.17 M(+57.6%) | -$3.99 M(-2.0%) |
| Apr 2018 | - | -$742.50 K(-44.6%) | -$4.07 M(-7.6%) |
| Jan 2018 | - | -$1.34 M(+81.3%) | -$4.41 M(+16.1%) |
| Oct 2017 | -$3.80 M(+12.3%) | -$739.30 K(-40.9%) | -$3.80 M(+1.5%) |
| Jul 2017 | - | -$1.25 M(+16.2%) | -$3.74 M(+13.2%) |
| Apr 2017 | - | -$1.08 M(+47.5%) | -$3.30 M(-7.7%) |
| Jan 2017 | - | -$729.90 K(+6.9%) | -$3.58 M(+5.8%) |
| Oct 2016 | -$3.38 M(-348.0%) | -$683.00 K(-16.2%) | -$3.38 M(-3.4%) |
| Jul 2016 | - | -$814.70 K(-39.7%) | -$3.50 M(+3.1%) |
| Apr 2016 | - | -$1.35 M(+153.9%) | -$3.39 M(-11.2%) |
| Jan 2016 | - | -$532.40 K(-33.6%) | -$3.82 M(-380.3%) |
| Oct 2015 | $1.36 M(-157.3%) | -$801.90 K(+13.2%) | $1.36 M(-24.4%) |
| Jul 2015 | - | -$708.50 K(-60.2%) | $1.80 M(-17.1%) |
| Apr 2015 | - | -$1.78 M(-138.2%) | $2.17 M(-36.9%) |
| Jan 2015 | - | $4.65 M(-1385.0%) | $3.45 M(-244.8%) |
| Oct 2014 | -$2.38 M(-25.3%) | -$362.10 K(+7.4%) | -$2.38 M(-7.1%) |
| Jul 2014 | - | -$337.30 K(-33.6%) | -$2.56 M(-16.4%) |
| Apr 2014 | - | -$507.80 K(-56.7%) | -$3.06 M(-11.7%) |
| Jan 2014 | - | -$1.17 M(+115.3%) | -$3.47 M(+8.8%) |
| Oct 2013 | -$3.19 M(+1.5%) | -$544.40 K(-35.2%) | -$3.19 M(-11.6%) |
| Jul 2013 | - | -$839.70 K(-8.0%) | -$3.60 M(+6.2%) |
| Apr 2013 | - | -$912.70 K(+2.6%) | -$3.39 M(+0.6%) |
| Jan 2013 | - | -$890.00 K(-7.5%) | -$3.37 M(+7.4%) |
| Oct 2012 | -$3.14 M(+338.6%) | -$962.40 K(+53.2%) | -$3.14 M(+8.6%) |
| Jul 2012 | - | -$628.40 K(-29.6%) | -$2.89 M(+210.8%) |
| Apr 2012 | - | -$892.60 K(+35.8%) | -$930.20 K(+21.8%) |
| Jan 2012 | - | -$657.30 K(-7.7%) | -$763.70 K(+6.7%) |
| Oct 2011 | -$716.00 K(-70.2%) | -$712.50 K(-153.5%) | -$716.00 K(+37.5%) |
| Jul 2011 | - | $1.33 M(-283.5%) | -$520.60 K(-79.0%) |
| Apr 2011 | - | -$726.10 K(+19.1%) | -$2.48 M(+12.7%) |
| Jan 2011 | - | -$609.60 K(+17.9%) | -$2.20 M(-8.5%) |
| Oct 2010 | -$2.41 M(-3.8%) | -$517.10 K(-17.8%) | -$2.41 M(-0.2%) |
| Jul 2010 | - | -$629.10 K(+41.1%) | -$2.41 M(+2.8%) |
| Apr 2010 | - | -$445.70 K(-45.2%) | -$2.35 M(-11.7%) |
| Jan 2010 | - | -$813.80 K(+55.7%) | -$2.66 M(+6.3%) |
| Oct 2009 | -$2.50 M(+177.4%) | -$522.70 K(-7.3%) | -$2.50 M(-4.3%) |
| Jul 2009 | - | -$563.80 K(-25.6%) | -$2.61 M(+241.5%) |
| Apr 2009 | - | -$757.80 K(+15.3%) | -$765.40 K(+5.7%) |
| Jan 2009 | - | -$657.40 K(+3.5%) | -$724.40 K(-19.7%) |
| Oct 2008 | -$901.90 K(-62.4%) | -$635.20 K(-149.4%) | -$901.90 K(+13.0%) |
| Jul 2008 | - | $1.28 M(-279.3%) | -$798.00 K(-69.6%) |
| Apr 2008 | - | -$716.80 K(-14.1%) | -$2.63 M(+8.0%) |
| Jan 2008 | - | -$834.90 K(+57.1%) | -$2.43 M(+1.4%) |
| Oct 2007 | -$2.40 M | -$531.30 K(-2.1%) | -$2.40 M(+8.1%) |
| Jul 2007 | - | -$542.50 K(+4.1%) | -$2.22 M(+3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2007 | - | -$521.20 K(-35.0%) | -$2.15 M(-4.6%) |
| Jan 2007 | - | -$801.90 K(+128.6%) | -$2.25 M(+21.8%) |
| Oct 2006 | -$1.85 M(+7.4%) | -$350.80 K(-26.0%) | -$1.85 M(-3.9%) |
| Jul 2006 | - | -$473.80 K(-24.1%) | -$1.92 M(+2.1%) |
| Apr 2006 | - | -$624.20 K(+56.7%) | -$1.88 M(+13.8%) |
| Jan 2006 | - | -$398.40 K(-6.2%) | -$1.65 M(-3.9%) |
| Oct 2005 | -$1.72 M(+42.8%) | -$424.80 K(-2.3%) | -$1.72 M(+1.8%) |
| Jul 2005 | - | -$434.60 K(+9.8%) | -$1.69 M(+3.4%) |
| Apr 2005 | - | -$395.80 K(-14.9%) | -$1.63 M(+16.1%) |
| Jan 2005 | - | -$465.00 K(+18.1%) | -$1.41 M(+16.7%) |
| Oct 2004 | -$1.21 M(+25.7%) | -$393.90 K(+4.1%) | -$1.21 M(+4.4%) |
| Jul 2004 | - | -$378.50 K(+123.8%) | -$1.15 M(+35.1%) |
| Apr 2004 | - | -$169.10 K(-35.9%) | -$854.60 K(-8.7%) |
| Jan 2004 | - | -$263.70 K(-23.1%) | -$936.20 K(-2.3%) |
| Oct 2003 | -$958.50 K(+122.1%) | -$343.10 K(+336.0%) | -$958.60 K(-9.5%) |
| Jul 2003 | - | -$78.70 K(-68.6%) | -$1.06 M(-42.0%) |
| Apr 2003 | - | -$250.70 K(-12.4%) | -$1.83 M(-36.6%) |
| Jan 2003 | - | -$286.10 K(-35.6%) | -$2.88 M(+567.6%) |
| Oct 2002 | -$431.50 K(-39.9%) | -$444.00 K(-47.5%) | -$431.50 K(-37.1%) |
| Jul 2002 | - | -$845.60 K(-35.2%) | -$686.20 K(-135.9%) |
| Apr 2002 | - | -$1.30 M(-160.3%) | $1.91 M(-22.6%) |
| Jan 2002 | - | $2.16 M(-409.6%) | $2.47 M(-444.0%) |
| Oct 2001 | -$717.80 K(-85.2%) | -$698.70 K(-139.9%) | -$717.90 K(-52.1%) |
| Jul 2001 | - | $1.75 M(-334.4%) | -$1.50 M(-65.9%) |
| Apr 2001 | - | -$747.70 K(-27.0%) | -$4.40 M(-9.5%) |
| Jan 2001 | - | -$1.02 M(-30.8%) | -$4.86 M(+0.5%) |
| Oct 2000 | -$4.84 M(-20.6%) | -$1.48 M(+28.7%) | -$4.84 M(-4.4%) |
| Jul 2000 | - | -$1.15 M(-5.1%) | -$5.06 M(-11.4%) |
| Apr 2000 | - | -$1.21 M(+21.1%) | -$5.71 M(+0.2%) |
| Jan 2000 | - | -$1.00 M(-41.2%) | -$5.70 M(-6.6%) |
| Oct 1999 | -$6.10 M(-20.8%) | -$1.70 M(-5.6%) | -$6.10 M(+1.7%) |
| Jul 1999 | - | -$1.80 M(+50.0%) | -$6.00 M(-3.2%) |
| Apr 1999 | - | -$1.20 M(-14.3%) | -$6.20 M(-13.9%) |
| Jan 1999 | - | -$1.40 M(-12.5%) | -$7.20 M(-6.5%) |
| Oct 1998 | -$7.70 M(-24.5%) | -$1.60 M(-20.0%) | -$7.70 M(-12.5%) |
| Jul 1998 | - | -$2.00 M(-9.1%) | -$8.80 M(-8.3%) |
| Apr 1998 | - | -$2.20 M(+15.8%) | -$9.60 M(+1.1%) |
| Jan 1998 | - | -$1.90 M(-29.6%) | -$9.50 M(-6.9%) |
| Oct 1997 | -$10.20 M(+142.9%) | -$2.70 M(-3.6%) | -$10.20 M(+17.2%) |
| Jul 1997 | - | -$2.80 M(+33.3%) | -$8.70 M(+20.8%) |
| Apr 1997 | - | -$2.10 M(-19.2%) | -$7.20 M(+18.0%) |
| Jan 1997 | - | -$2.60 M(+116.7%) | -$6.10 M(+45.2%) |
| Oct 1996 | -$4.20 M(+44.8%) | -$1.20 M(-7.7%) | -$4.20 M(+7.7%) |
| Jul 1996 | - | -$1.30 M(+30.0%) | -$3.90 M(+14.7%) |
| Apr 1996 | - | -$1.00 M(+42.9%) | -$3.40 M(+13.3%) |
| Jan 1996 | - | -$700.00 K(-22.2%) | -$3.00 M(+3.4%) |
| Oct 1995 | -$2.90 M(-19.4%) | -$900.00 K(+12.5%) | -$2.90 M(+3.6%) |
| Jul 1995 | - | -$800.00 K(+33.3%) | -$2.80 M(-3.4%) |
| Apr 1995 | - | -$600.00 K(0.0%) | -$2.90 M(-9.4%) |
| Jan 1995 | - | -$600.00 K(-25.0%) | -$3.20 M(-11.1%) |
| Oct 1994 | -$3.60 M(+38.5%) | -$800.00 K(-11.1%) | -$3.60 M(+2.9%) |
| Jul 1994 | - | -$900.00 K(0.0%) | -$3.50 M(+6.1%) |
| Apr 1994 | - | -$900.00 K(-10.0%) | -$3.30 M(+10.0%) |
| Jan 1994 | - | -$1.00 M(+42.9%) | -$3.00 M(+15.4%) |
| Oct 1993 | -$2.60 M(+52.9%) | -$700.00 K(0.0%) | -$2.60 M(+8.3%) |
| Jul 1993 | - | -$700.00 K(+16.7%) | -$2.40 M(+14.3%) |
| Apr 1993 | - | -$600.00 K(0.0%) | -$2.10 M(+10.5%) |
| Jan 1993 | - | -$600.00 K(+20.0%) | -$1.90 M(+11.8%) |
| Oct 1992 | -$1.70 M(+41.7%) | -$500.00 K(+25.0%) | -$1.70 M(+13.3%) |
| Jul 1992 | - | -$400.00 K(0.0%) | -$1.50 M(+7.1%) |
| Apr 1992 | - | -$400.00 K(0.0%) | -$1.40 M(+7.7%) |
| Jan 1992 | - | -$400.00 K(+33.3%) | -$1.30 M(+8.3%) |
| Oct 1991 | -$1.20 M(+9.1%) | -$300.00 K(0.0%) | -$1.20 M(0.0%) |
| Jul 1991 | - | -$300.00 K(0.0%) | -$1.20 M(0.0%) |
| Apr 1991 | - | -$300.00 K(0.0%) | -$1.20 M(+9.1%) |
| Jan 1991 | - | -$300.00 K(0.0%) | -$1.10 M(0.0%) |
| Oct 1990 | -$1.10 M(+10.0%) | -$300.00 K(0.0%) | -$1.10 M(+37.5%) |
| Jul 1990 | - | -$300.00 K(+50.0%) | -$800.00 K(+60.0%) |
| Apr 1990 | - | -$200.00 K(-33.3%) | -$500.00 K(+66.7%) |
| Jan 1990 | - | -$300.00 K | -$300.00 K |
| Oct 1989 | -$1.00 M | - | - |
FAQ
- What is Anixa Biosciences annual cash flow from operations?
- What is the all time high annual CFO for Anixa Biosciences?
- What is Anixa Biosciences annual CFO year-on-year change?
- What is Anixa Biosciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Anixa Biosciences?
- What is Anixa Biosciences quarterly CFO year-on-year change?
- What is Anixa Biosciences TTM cash flow from operations?
- What is the all time high TTM CFO for Anixa Biosciences?
- What is Anixa Biosciences TTM CFO year-on-year change?
What is Anixa Biosciences annual cash flow from operations?
The current annual CFO of ANIX is -$7.33 M
What is the all time high annual CFO for Anixa Biosciences?
Anixa Biosciences all-time high annual cash flow from operations is $1.36 M
What is Anixa Biosciences annual CFO year-on-year change?
Over the past year, ANIX annual cash flow from operations has changed by -$1.13 M (-18.13%)
What is Anixa Biosciences quarterly cash flow from operations?
The current quarterly CFO of ANIX is -$927.00 K
What is the all time high quarterly CFO for Anixa Biosciences?
Anixa Biosciences all-time high quarterly cash flow from operations is $4.65 M
What is Anixa Biosciences quarterly CFO year-on-year change?
Over the past year, ANIX quarterly cash flow from operations has changed by +$1.04 M (+52.92%)
What is Anixa Biosciences TTM cash flow from operations?
The current TTM CFO of ANIX is -$7.33 M
What is the all time high TTM CFO for Anixa Biosciences?
Anixa Biosciences all-time high TTM cash flow from operations is $3.45 M
What is Anixa Biosciences TTM CFO year-on-year change?
Over the past year, ANIX TTM cash flow from operations has changed by -$1.13 M (-18.13%)